These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10208481)

  • 1. Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells.
    Maziere C; Conte MA; Dantin F; Maziere JC
    Atherosclerosis; 1999 Mar; 143(1):75-80. PubMed ID: 10208481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells.
    Maziere C; Djavahery-Mergny M; Auclair M; Maziere JC
    Biochim Biophys Acta; 1994 Jan; 1210(2):233-8. PubMed ID: 8280775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein.
    Mazière C; Auclair M; Ronveaux MF; Salmon S; Santus R; Mazière JC
    Atherosclerosis; 1991 Aug; 89(2-3):175-82. PubMed ID: 1793445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen protects low density lipoproteins against oxidative modification.
    Zapolska-Downar D; Zapolska-Downar A; Bukowska H; Gałka H; Naruszewicz M
    Life Sci; 1999; 65(22):2289-303. PubMed ID: 10597884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyunsaturated fatty acid enrichment enhances endothelial cell-induced low-density-lipoprotein peroxidation.
    Mazière C; Dantin F; Conte MA; Degonville J; Ali D; Dubois F; Mazière JC
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):57-62. PubMed ID: 9806884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole inhibits the oxidative modification of low density lipoprotein.
    Selley ML; Czeti AL; McGuiness JA; Ardlie NG
    Atherosclerosis; 1994 Nov; 111(1):91-7. PubMed ID: 7840817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.
    Sparrow CP; Parthasarathy S; Steinberg D
    J Lipid Res; 1988 Jun; 29(6):745-53. PubMed ID: 3139813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
    Parthasarathy S; Barnett J; Fong LG
    Biochim Biophys Acta; 1990 May; 1044(2):275-83. PubMed ID: 2344447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism.
    Mukhopadhyay CK; Ehrenwald E; Fox PL
    J Biol Chem; 1996 Jun; 271(25):14773-8. PubMed ID: 8663020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.
    Heinecke JW; Rosen H; Chait A
    J Clin Invest; 1984 Nov; 74(5):1890-4. PubMed ID: 6501577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation.
    Niu XL; Xia Y; Hoshiai K; Tanaka K; Sawamura S; Nakazawa H
    Nitric Oxide; 2000 Aug; 4(4):363-71. PubMed ID: 10944420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro.
    Mougenot N; Lesnik P; Ramirez-Gil JF; Nataf P; Diczfalusy U; Chapman MJ; Lechat P
    Atherosclerosis; 1997 Sep; 133(2):183-92. PubMed ID: 9298678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.
    Heinecke JW; Baker L; Rosen H; Chait A
    J Clin Invest; 1986 Mar; 77(3):757-61. PubMed ID: 3005364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR; Loo G
    J Pineal Res; 1997 May; 22(4):203-9. PubMed ID: 9247205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation.
    Mazière C; Auclair M; Rose-Robert F; Leflon P; Mazière JC
    FEBS Lett; 1995 Apr; 363(3):277-9. PubMed ID: 7737416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells.
    Rikitake Y; Hirata K; Kawashima S; Akita H; Yokoyama M
    Atherosclerosis; 1998 Jan; 136(1):51-7. PubMed ID: 9544731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of resveratrol on oxidative modification of human low density lipoprotein.
    Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
    Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen.
    Kalant N; McCormick S; Parniak MA
    Arterioscler Thromb; 1991; 11(5):1322-9. PubMed ID: 1911719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.
    Hurt-Camejo E; Camejo G; Rosengren B; López F; Ahlström C; Fager G; Bondjers G
    Arterioscler Thromb; 1992 May; 12(5):569-83. PubMed ID: 1576119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized LDL from subjects with different dietary habits modifies atherogenic processes in endothelial and smooth muscle cells.
    Lähteenmäki TA; Seppo L; Laakso J; Korpela R; Vanhanen H; Tikkanen MJ; Vapaatalo H
    Life Sci; 2000; 66(5):455-65. PubMed ID: 10670834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.